Meteoreisen is a remedy from anthroposophic medicine, a European healing tradition: sugar globules combining meteoric iron, phosphorus and quartz in extreme dilutions, sold for flu-like infections, slow recovery after illness and general exhaustion. No retrievable study has tested it; related remedies showed no consistent benefit. Direct harms appear rare and not serious; treating lasting exhaustion with it can postpone finding a correctable cause. Nothing links it to longer life. (Full Review)

Protocol

Standard dose (label)

5–10 globules 1–3 times daily

Dissolved sublingually (under the tongue); adults and children from 12 years

Single or split doses

Split during the acute phase

Single daily dose in recovery (common practice)

Time of day

Spread across waking hours

Kept apart from coffee; no source specifies a time (common practice)

Time to effect

Acute illness

Within 2–7 days

Leaflet expectation (2 days German, 7 days Austrian), otherwise medical review; no study has measured it

Benefits

Low: Relief of general exhaustion and delayed convalescence; faster recovery from flu-like infections

Speculative: Healthspan or longevity effects; improved warmth regulation

Contraindications

Known allergy to meteoric iron, phosphorus, quartz or the inactive ingredients

Children under 1 year (Austrian product)

Known sugar intolerance, unless a physician has been consulted

Fever above 39 °C or persistent or unclear complaints, as a sole treatment without medical review

Pregnancy or breastfeeding, unless a physician or pharmacist has been consulted

Key Interactions

Drugs bound by oral iron (levothyroxine, ciprofloxacin, doxycycline, alendronate): no interaction expected (theoretical)

Iron-modifying therapies (deferasirox, intravenous ferric carboxymaltose): no interaction expected (theoretical)

Over-the-counter fever reducers (paracetamol, ibuprofen): no pharmacological interaction (theoretical); lowering fever can mask the 39 °C threshold for medical review

Oral iron supplements (ferrous sulfate, ferrous bisglycinate): no interaction (theoretical)

Supplements with additive aims (vitamin D, zinc, other anthroposophic or homeopathic globules): no additive pharmacological effect (theoretical)

Stimulants and strong aromatic substances (coffee, alcohol, menthol, camphor): may weaken the remedy's effect (caution, theoretical)

Risk & Side Effects

Low: Delayed diagnosis of a treatable cause of fatigue; transient symptom aggravation or hypersensitivity

Speculative: Sugar load in sugar intolerance; contamination or dilution errors; new symptoms with prolonged unsupervised use

Monitoring

Marker	Target	Why
Hemoglobin	Women about 12.0–15.5 g/dL; men about 13.5–17.5 g/dL	Safety check: anemia redirects to targeted treatment
Ferritin	Women about 15–150 ng/mL; men about 30–400 ng/mL	Safety check: low stores change use
TSH (thyroid-stimulating hormone)	About 0.4–4.0 mIU/L	Safety check: thyroid disease changes use
Fatigue Severity Scale score	No established target; track change from own baseline	Expected to change: measures the claimed effect
CRP (C-reactive protein)	No range stated; paired with ferritin	Ferritin rises with inflammation
Body temperature	Medical review above 39 °C	Safety check: fever threshold for medical review

Cadence: Baseline blood count, ferritin, thyroid function and fatigue score before use for exhaustion lasting more than a few weeks; temperature daily during acute illness; symptom review at 2 and 7 days; fatigue score at 2 weeks; repeat blood tests at 3 months only if exhaustion persists or results were abnormal.

Qualitative Assessment

Energy on waking and in the afternoon
Days until return to usual activity after an infection
Exercise tolerance and recovery after training
Sleep quality and daytime alertness
Mood and motivation (drive)

Meteoreisen for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment